Back to all issues
Issue #17
November 11, 2025

IDoR 2025 Special Edition · Radiology AI Snapshot 2025

PLUS: See the numbers: MRI leads papers, CT leads products, 2025 breaks records

RadAI Slice Newsletter

Weekly Updates in Radiology AI

International Day of Radiology · Special Edition

Radiology AI Snapshot 2025

Good morning there. You know we keep an eye on radiology AI every week. This special IDoR issue looks at what really changed in 2025 — the trends, the clearances, and the gaps still holding things back.


Here’s your quick catch-up:

• MRI leads research, but CT and multimodal tools get most FDA clears.

• Labs love classification and segmentation, hospitals rely on detection and triage.

• MRI and classification show the widest gap between papers and products.

• Too few studies reach real clinical use; stronger multi site trials are key.

• 2025 is on track for record AI clearances with more workflow integrated tools.

View the full report

MRI leads the papers, CT drives the clearances

MRI continues to dominate research, but CT and multimodal systems are the ones reaching the market. It shows how vendors focus on technologies that are already part of daily hospital workflows.

Research vs FDA by modality

💬 Meet RadAIChat

Chat side by side with leading imaging AI models.

Compare their results instantly and see what each one finds.

Try RadAIChat →

Segmentation stays popular, detection gets deployed

Researchers continue to explore classification and segmentation, while hospitals focus on detection and triage — the tools that make the biggest difference in urgent workflows.

Research vs FDA by task

The translation gap

For every FDA cleared tool, there are hundreds of models that never leave the lab. The widest gaps appear in MRI and classification, reminding us that the challenge is not in building models but in proving they work in real settings.

Research − FDA gaps

A narrow evidence funnel

Thousands of studies are published each year, yet only a small share make it to clinical pilots, and even fewer reach FDA clearance. Shared datasets and stronger multi site trials could be the key to progress in 2026.

Evidence funnel

FDA momentum keeps building

2025 is shaping up to be another record year for AI and machine learning devices. Expect to see more combination tools that link imaging analysis with structured reporting and workflow support.

FDA approvals by year

Our dataset keeps updating as new papers and FDA filings come in. You can always check the latest numbers here.

Read the full Snapshot

That's it for today!

Before you go we’d love to know what you thought of today's newsletter to help us improve the RadAI Slice experience for you.

⭐⭐⭐⭐⭐ Nailed it
⭐⭐⭐ Average
⭐ Fail

👋 Quick favor: drag this into your Primary tab so you don’t miss next week. Or just hit Reply with one thought.

See you next week.


P.S. We keep building free tools to accelerate your radiology work. What's the most time-consuming pain point in your day that we should help speed up? Reply and share your take so we keep building around you.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.